Basic Information
ID: ALA5168105
Type: Functional
Description: Antiproliferative activity against human Hep3B cells expressing FGF19/FGFR4 assessed as inhibition of cell growth incubated for 72 hrs by CCK-8 assay
Format: BAO_0000219
Organism: Homo sapiens
Cell type: Hep 3B2
Target: Hep 3B2(ALA4296437)
Document: ALA5154932
Antiproliferative activity against human Hep3B cells expressing FGF19/FGFR4 assessed as inhibition of cell growth incubated for 72 hrs by CCK-8 assay: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA5168105
IC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 444.32 | 4.76 | 4.76 |
| 503.39 | 4.49 | 4.49 |
| 654.60 | 6.21 | 6.21 |
| 553.45 | 6.58 | 6.58 |
| 694.66 | 7.13 | 7.13 |
| 650.61 | 6.65 | 6.65 |
| 636.58 | 6.34 | 6.34 |
| 706.67 | 7.13 | 7.13 |
| 565.46 | 6.90 | 6.90 |
| 651.60 | 6.42 | 6.42 |
| 590.47 | 6.82 | 6.82 |
| 680.59 | 5.88 | 5.88 |
| 590.47 | 6.82 | 6.82 |
| 547.44 | 4.28 | 4.28 |
| 693.63 | 7.21 | 7.21 |
| 678.62 | 6.19 | 6.19 |
| 651.55 | 6.19 | 6.19 |
| 593.51 | 7.68 | 7.68 |
| 533.42 | 7.27 | 7.27 |
| 554.43 | 6.21 | 6.21 |
| 525.39 | 6.09 | 6.09 |
| 607.42 | 7.13 | 7.13 |
| 666.61 | 6.39 | 6.39 |
| 681.62 | 6.43 | 6.43 |
| 563.44 | 7.28 | 7.28 |
| 663.56 | 6.02 | 6.02 |
| 667.59 | 5.74 | 5.74 |
| 569.45 | 6.28 | 6.28 |
| 559.45 | 4.59 | 4.59 |
| 666.61 | 6.35 | 6.35 |
| 551.41 | 7.41 | 7.41 |